The psychopharmacology algorithm project at the Harvard South Shore Program: an algorithm for acute mania

Area of Science:

• Psychiatry
• Pharmacology
• Clinical Medicine

Background:

• Acute mania requires effective pharmacotherapy to manage symptoms and prevent relapse.
• Existing treatment guidelines may not fully address the complexities of mixed versus non-mixed mania.
• Optimizing treatment involves balancing efficacy, long-term outcomes, and side effect profiles.

Purpose of the Study:

• To develop a novel, evidence-based algorithm for the pharmacotherapy of acute mania.
• To provide clinicians with a structured approach to treatment selection for both mixed and non-mixed mania.
• To integrate considerations of efficacy, relapse prevention, and side effect management into treatment decisions.

Main Methods:

• Comprehensive literature search of PubMed and review of key studies, algorithms, and guidelines.
• Development of distinct treatment algorithms for mixed and non-mixed mania.
• Prioritization of treatments based on effectiveness, relapse prevention, and side effect minimization.

Main Results:

• For mixed mania, initial treatment with quetiapine (a second-generation antipsychotic) is recommended, followed by valproate and potentially lithium or carbamazepine.
• For non-mixed mania, lithium is the first-line recommendation, with second-generation antipsychotics (quetiapine favored) as an adjunct.
• A tiered approach is outlined for treatment-resistant mania, including various antipsychotics, mood stabilizers, and electroconvulsive therapy.

Conclusions:

• The proposed algorithm offers a systematic approach to pharmacotherapy for acute mania.
• Tailored strategies for mixed and non-mixed mania improve treatment selection.
• The algorithm emphasizes a balanced consideration of efficacy, relapse prevention, and long-term safety.